Accelerating NDA filing through faster carcinogenicity assessment
Drug Discovery World
MAY 10, 2023
This stage is more highly regulated and consists of both preclinical testing and clinical trials. Carcinogenicity testing For decades, the two-year rodent bioassay has been the regulatory standard used to determine the carcinogenic potential of new drugs. In practice, this was typically conducted in rats and mice.
52 
Let's personalize your content